SOTYKTU (deucravacitinib) is a prescription medicine used to treat adults with moderate-to-severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy). It is not known if SOTYKTU is safe and effective in children under 18 years of age.
ADDITIONAL RESOURCES IN YOUR CORNER
Your dermatologist should always be your go-to person to discuss your moderate to severe plaque psoriasis. After all, they understand you and your goals.
Yet at times, you may want a little more support and information, or someone else to talk to. Reaching out to one of the helpful organizations below may help.
The Autoimmune Association is the world's leading nonprofit organization dedicated to autoimmune awareness, advocacy, education, and research.
The Global Healthy Living Foundation seeks to
inspire, support, and empower people living with
chronic illnesses. They offer evidence-based education and tools that help people living with serious and often lifelong conditions.